814,223 Shares in Guardian Pharmacy Services, Inc. $GRDN Purchased by TimesSquare Capital Management LLC

TimesSquare Capital Management LLC purchased a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the second quarter, according to the company in its most recent filing with the SEC. The fund purchased 814,223 shares of the company’s stock, valued at approximately $17,351,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Envestnet Asset Management Inc. lifted its holdings in shares of Guardian Pharmacy Services by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after purchasing an additional 805 shares in the last quarter. Allspring Global Investments Holdings LLC lifted its stake in Guardian Pharmacy Services by 0.5% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 285,885 shares of the company’s stock valued at $6,092,000 after acquiring an additional 1,338 shares in the last quarter. Parkside Financial Bank & Trust purchased a new position in Guardian Pharmacy Services during the 2nd quarter worth $41,000. KLP Kapitalforvaltning AS purchased a new position in Guardian Pharmacy Services during the 2nd quarter worth $75,000. Finally, Meeder Asset Management Inc. bought a new stake in shares of Guardian Pharmacy Services in the 1st quarter worth $88,000.

Guardian Pharmacy Services Stock Up 1.2%

NYSE GRDN opened at $31.63 on Thursday. The company has a market cap of $2.00 billion, a PE ratio of 50.21 and a beta of 0.96. Guardian Pharmacy Services, Inc. has a 52 week low of $17.78 and a 52 week high of $37.43. The firm’s 50-day simple moving average is $26.98 and its two-hundred day simple moving average is $24.02.

Guardian Pharmacy Services (NYSE:GRDN) last released its quarterly earnings data on Monday, November 10th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.01. Guardian Pharmacy Services had a net margin of 2.90% and a return on equity of 30.29%. The business had revenue of $377.43 million during the quarter, compared to analyst estimates of $381.16 million. Guardian Pharmacy Services has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analyst Ratings Changes

GRDN has been the topic of several analyst reports. Weiss Ratings upgraded shares of Guardian Pharmacy Services from a “sell (d+)” rating to a “hold (c)” rating in a report on Tuesday. Wall Street Zen lowered Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a report on Sunday. Truist Financial increased their price target on Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, September 26th. Finally, Oppenheimer began coverage on Guardian Pharmacy Services in a research report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat.com, Guardian Pharmacy Services currently has an average rating of “Moderate Buy” and a consensus target price of $29.33.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.